Skip to main content
logo
Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
547.09
+4.59 (0.85%)
At close: Nov 6, 2026, 4:00 PM EST
550.41
+3.32 (0.61%)
Pre-market: Nov 9, 2026, 6:30 AM EST

Vertex Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
12,95212,00111,0209,8698,9317,574
Revenue Growth
10.48%8.90%11.66%10.51%17.91%22.06%
Gross Profit
7,0996,4415,8595,4445,3234,732
Operating Income
4,8954,6874,3954,3084,3783,892
Net Income
3,9763,953-535.63,6203,3222,342
Earnings Per Share
15.5515.32-2.0813.8912.829.01
EPS Growth
9.33%--8.35%42.29%-12.44%

Revenue by Segment
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Trikafta / Kaftrio
9,86110,31310,2398,9457,6875,697
Alyftrek
2,084837.8----
Casgevy
272.8115.810---
Journavx
163.659.6----
Other Collaborative and Royalty
-30.7---1
Other
-644.7771.5924.51,2441,876
Revenue (Total)
12,95212,00111,0209,8698,9317,574

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9,82112,32011,22413,71610,8917,525
Total Debt
6,4782,0361,750808.4899.7967.4
Net Cash (Debt)
3,34310,2849,47412,9089,9916,558
Net Cash Growth
-67.15%8.55%-26.60%29.19%52.36%14.71%
Net Cash Per Share
13.0739.8636.7449.5538.5625.23

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
3,6953,631-492.63,5374,1302,644
Capital Expenditures
-492.3-437.6-297.7-200.4-204.7-235
Free Cash Flow
3,2023,194-790.33,3373,9252,409
Free Cash Flow Growth
-4.04%---14.99%62.97%-19.55%

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
54.81%53.66%53.17%55.16%59.60%62.48%
Operating Margin
37.79%39.06%39.88%43.65%49.03%51.39%
Pretax Margin
36.75%38.69%2.25%44.38%47.39%36.05%
Profit Margin
30.70%32.94%-4.86%36.68%37.20%30.92%
FCF Margin
24.73%26.61%-7.17%33.81%43.95%31.80%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
35.1829.10-28.9722.3123.84
Forward PE
29.0022.6122.6624.4418.8316.42
P/FCF Ratio
43.3236.02-31.4218.8923.18
PS Ratio
10.719.589.4110.628.307.37